Natural essential oils derived from herbal medicines: A promising therapy strategy for treating cognitive impairment
暂无分享,去创建一个
Yue Hu | Yue Hu | Xiaofang He | Yu Long | Nan Li | Dan Li | Ai Shi | Yuanyuan Wu | Dan Li | Shuang Yu | Xiaoqiu Li | Jing Wen | Yini Ma | Yue Hu | Yuan Hu | J. Deng | Shuang Yu | Yuan Hu | Ai Shi | Yu Long | Xiaoqiu Li
[1] Yuan Zhang,et al. Bromo-protopine, a novel protopine derivative, alleviates tau pathology by activating chaperone-mediated autophagy for Alzheimer’s disease therapy , 2022, Frontiers in Molecular Biosciences.
[2] A. Bera,et al. Reduction of kinesin I heavy chain decreases tau hyperphosphorylation, aggregation, and memory impairment in Alzheimer’s disease and tauopathy models , 2022, Frontiers in Molecular Biosciences.
[3] K. Cheung,et al. Tetrandrine ameliorates cognitive deficits and mitigates tau aggregation in cell and animal models of tauopathies , 2022, Journal of Biomedical Science.
[4] Shi-Jie Zhang,et al. Ligustilide Improves Cognitive Impairment via Regulating the SIRT1/IRE1α/XBP1s/CHOP Pathway in Vascular Dementia Rats , 2022, Oxidative medicine and cellular longevity.
[5] Yinhui Li,et al. Real-Time Detection and Visualization of Amyloid-β Aggregates Induced by Hydrogen Peroxide in Cell and Mouse Models of Alzheimer’s Disease , 2022, ACS applied materials & interfaces.
[6] Shi-Jie Zhang,et al. Ligustilide ameliorates cognitive impairment via AMPK/SIRT1 pathway in vascular dementia rat , 2022, Metabolic Brain Disease.
[7] Yin Tang,et al. Effects of Peppermint Essential Oil on Learning and Memory Ability in APP/PS1 Transgenic Mice , 2022, Molecules.
[8] Lin F. Yang,et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019 , 2022, The Lancet. Public health.
[9] K. Shyamprasad,et al. A standardized black pepper seed extract containing β-caryophyllene improves cognitive function in scopolamine-induced amnesia model mice via regulation of brain-derived neurotrophic factor and MAPK proteins. , 2021, Journal of food biochemistry.
[10] G. Cui,et al. Oxyphylla A ameliorates cognitive deficits and alleviates neuropathology via the Akt-GSK3β and Nrf2-Keap1-HO-1 pathways in vitro and in vivo murine models of Alzheimer's disease , 2021, Journal of advanced research.
[11] K. Rajaram,et al. Alzheimer's Disease and other Tauopathies: Exploring Efficacy of Medicinal Plant-Derived Compounds in Alleviating Tau-Mediated Neurodegeneration. , 2021, Current molecular pharmacology.
[12] Shen-Shih Chiang,et al. Ameliorating Effect on Aβ-Induced Alzheimer’s Mice by Litsea cubeba Persoon Powder , 2021, Molecules.
[13] Zhongshen Kuang,et al. β-Asarone Attenuates Aβ-Induced Neuronal Damage in PC12 Cells Overexpressing APPswe by Restoring Autophagic Flux , 2021, Frontiers in Pharmacology.
[14] A. Secondo,et al. The Antioxidant Activity of Limonene Counteracts Neurotoxicity Triggered byAβ1-42 Oligomers in Primary Cortical Neurons , 2021, Antioxidants.
[15] S. Tufik,et al. Lavender essential oil on postmenopausal women with insomnia: double-blind randomized trial. , 2021, Complementary therapies in medicine.
[16] K. Cho,et al. Linalool Alleviates Aβ42-Induced Neurodegeneration via Suppressing ROS Production and Inflammation in Fly and Rat Models of Alzheimer's Disease , 2021, Oxidative medicine and cellular longevity.
[17] Hyung-Won Kang,et al. A systematic literature review and meta-analysis of the clinical effects of aroma inhalation therapy on sleep problems , 2021, Medicine.
[18] Jing Cheng,et al. Ginkgolide B promotes oligodendrocyte precursor cell differentiation and survival via Akt/CREB/bcl-2 signaling pathway after white matter lesion , 2021, Experimental biology and medicine.
[19] H. Isoda,et al. Dietary administration of cumin-derived cuminaldehyde induce neuroprotective and learning and memory enhancement effects to aging mice , 2021, Aging.
[20] Hong-Bing Wang,et al. Essential Oil of Acorus tatarinowii Schott Ameliorates Aβ-Induced Toxicity in Caenorhabditis elegans through an Autophagy Pathway , 2020, Oxidative medicine and cellular longevity.
[21] P. Yaghmaei,et al. Effects of Terpinolene and Physical Activity on Memory and Learning in a Model of Alzheimer's Disease among Rats , 2020, Qom Univ Med Sci J.
[22] J. Jia,et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. , 2020, The Lancet. Public health.
[23] L. Hritcu,et al. Thymus vulgaris Essential Oil Protects Zebrafish against Cognitive Dysfunction by Regulating Cholinergic and Antioxidants Systems , 2020, Antioxidants.
[24] X. Yao,et al. Nrf2: a dark horse in Alzheimer's disease treatment , 2020, Ageing Research Reviews.
[25] A. Badr,et al. Sesame oil mitigates memory impairment, oxidative stress, and neurodegeneration in a rat model of Alzheimer's disease. A pivotal role of NF-κB/p38MAPK/BDNF/PPAR-γ pathways. , 2020, Journal of ethnopharmacology.
[26] Kalpesh Panara,et al. Central nervous system depressant activity of Jatamansi (Nardostachys jatamansi DC.) rhizome , 2020, Ayu.
[27] Shu Yang,et al. The effectiveness of aromatherapy on preoperative anxiety in adults: A systematic review and meta-analysis of randomized controlled trials. , 2020, International journal of nursing studies.
[28] Antonio Massa,et al. Lavender and coriander essential oils and their main component linalool exert a protective effect against amyloid‐β neurotoxicity , 2020, Phytotherapy research : PTR.
[29] A. Boguszewska-Czubara,et al. Bergapten Improves Scopolamine-Induced Memory Impairment in Mice via Cholinergic and Antioxidative Mechanisms , 2020, Frontiers in Neuroscience.
[30] Eric E. Smith,et al. Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.
[31] S. Singh,et al. Role of antioxidants and a nutrient rich diet in Alzheimer's disease , 2020, Open Biology.
[32] Xu Gao,et al. Lemon essential oil ameliorates age-associated cognitive dysfunction via modulating hippocampal synaptic density and inhibiting acetylcholinesterase , 2020, Aging.
[33] Changwei Wei,et al. Vascular cognitive impairment and dementia in type 2 diabetes mellitus: An overview. , 2020, Life sciences.
[34] Yuan Cheng,et al. Peripheral clearance of brain-derived Aβ in Alzheimer's disease: pathophysiology and therapeutic perspectives , 2020, Translational Neurodegeneration.
[35] P. Mortazavi,et al. Effect of β-asarone in normal and β-amyloid-induced Alzheimeric rats , 2020, Archives of medical science : AMS.
[36] G. Eren,et al. Cognitive Facilitation and Antioxidant Effects of an Essential Oil Mix on Scopolamine-Induced Amnesia in Rats: Molecular Modeling of In Vitro and In Vivo Approaches , 2020, Molecules.
[37] Liping Huang,et al. β-asarone modulates Beclin-1, LC3 and p62 expression to attenuate Aβ40 and Aβ42 levels in APP/PS1 transgenic mice with Alzheimer's disease , 2020, Molecular medicine reports.
[38] Qi Wang,et al. Ligustilide improves aging-induced memory deficit by regulating mitochondrial related inflammation in SAMP8 mice , 2020, Aging.
[39] R. Gabizon,et al. Brain targeting of 9c,11t-Conjugated Linoleic Acid, a natural calpain inhibitor, preserves memory and reduces Aβ and P25 accumulation in 5XFAD mice , 2019, Scientific Reports.
[40] Shi-feng Chu,et al. Effect of α-asarone on ethanol-induced learning and memory impairment in mice and its underlying mechanism. , 2019, Life sciences.
[41] Mengjie Xu,et al. Essential oil of Schisandra chinensis ameliorates cognitive decline in mice by alleviating inflammation. , 2019, Food & function.
[42] M. Nair,et al. Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics , 2019, International journal of nanomedicine.
[43] L. Robison,et al. Sex differences in risk factors for vascular contributions to cognitive impairment & dementia , 2019, Neurochemistry International.
[44] L. D. de Souza,et al. Alzheimer’s disease: risk factors and potentially protective measures , 2019, Journal of Biomedical Science.
[45] O. Cioancă,et al. Pinus halepensis essential oil attenuates the toxic Alzheimer's amyloid beta (1-42)-induced memory impairment and oxidative stress in the rat hippocampus. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[46] O. Cioancă,et al. Tetraclinis articulata essential oil mitigates cognitive deficits and brain oxidative stress in an Alzheimer's disease amyloidosis model. , 2019, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[47] S. Agatonovic-Kustrin,et al. Essential oils and functional herbs for healthy aging , 2019, Neural regeneration research.
[48] P. Tariot,et al. Present Algorithms and Future Treatments for Alzheimer’s Disease , 2019, Journal of Alzheimer's disease : JAD.
[49] R. Ihl,et al. Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761® , 2019, CNS neuroscience & therapeutics.
[50] Anil Kumar,et al. Targeting oxidative stress, acetylcholinesterase, proinflammatory cytokine, dopamine and GABA by eucalyptus oil (Eucalyptus globulus) to alleviate ketamine-induced psychosis in rats , 2019, Inflammopharmacology.
[51] Yong-Ku Kim,et al. Effectiveness of memantine on depression-like behavior, memory deficits and brain mRNA levels of BDNF and TrkB in rats subjected to repeated unpredictable stress , 2018, Pharmacological reports : PR.
[52] M. Mesulam,et al. The cholinergic system in the pathophysiology and treatment of Alzheimer's disease. , 2018, Brain : a journal of neurology.
[53] Wei Wang,et al. α-Cyperone inhibits LPS-induced inflammation in BV-2 cells through activation of Akt/Nrf2/HO-1 and suppression of the NF-κB pathway. , 2018, Food & function.
[54] K. Koike,et al. The effect of inhalation of essential oil from Rosmarinus officinalis on scopolamine‐induced Alzheimer's type dementia model mice , 2018 .
[55] H. Kuang,et al. Cognitive enhancement of volatile oil from the stems of Schisandra chinensis Baill. in Alzheimer's disease rats. , 2018, Canadian journal of physiology and pharmacology.
[56] O. Badary,et al. Protective effects of thymoquinone on D-galactose and aluminum chloride induced neurotoxicity in rats: biochemical, histological and behavioral changes , 2018, Neurological research.
[57] W. Hsu,et al. Mechanism of intranasal drug delivery directly to the brain , 2018, Life sciences.
[58] Gyu Hwan Park,et al. Neuroprotective Effect and Molecular Mechanism of [6]-Gingerol against Scopolamine-Induced Amnesia in C57BL/6 Mice , 2018, Evidence-based complementary and alternative medicine : eCAM.
[59] R. Mizrahi,et al. Molecular imaging of neuroinflammation in Alzheimer's disease and mild cognitive impairment , 2018, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[60] M. Kim,et al. Natural Dietary Supplementation of Anthocyanins via PI3K/Akt/Nrf2/HO-1 Pathways Mitigate Oxidative Stress, Neurodegeneration, and Memory Impairment in a Mouse Model of Alzheimer’s Disease , 2018, Molecular Neurobiology.
[61] Guy M. McKhann,et al. Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort , 2017, JAMA neurology.
[62] Meizhu Wang,et al. Rose Essential Oil Delayed Alzheimer's Disease-Like Symptoms by SKN-1 Pathway in C. elegans. , 2017, Journal of agricultural and food chemistry.
[63] M. Power,et al. Defining the Relationship Between Hypertension, Cognitive Decline, and Dementia: a Review , 2017, Current Hypertension Reports.
[64] Alan J. Thomas,et al. Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology , 2011, Journal of psychopharmacology.
[65] J. Gutiérrez Rodríguez,et al. [Definition and prevalence of mild cognitive impairment]. , 2017, Revista espanola de geriatria y gerontologia.
[66] Ming Yan,et al. Protective effect of lavender oil on scopolamine induced cognitive deficits in mice and H2O2 induced cytotoxicity in PC12 cells. , 2016, Journal of ethnopharmacology.
[67] Liping Huang,et al. β-asarone improves learning and memory and reduces Acetyl Cholinesterase and Beta-amyloid 42 levels in APP/PS1 transgenic mice by regulating Beclin-1-dependent autophagy , 2016, Brain Research.
[68] G. Cardona-Gómez,et al. Linalool reverses neuropathological and behavioral impairments in old triple transgenic Alzheimer's mice , 2016, Neuropharmacology.
[69] P. VandeVord,et al. Role of Glia in Memory Deficits Following Traumatic Brain Injury: Biomarkers of Glia Dysfunction , 2016, Front. Integr. Neurosci..
[70] J. Francis-Oliveira,et al. Reactive Oxygen Species: Physiological and Physiopathological Effects on Synaptic Plasticity , 2016, Journal of experimental neuroscience.
[71] Elyse Rosa,et al. CREB expression mediates amyloid β-induced basal BDNF downregulation , 2015, Neurobiology of Aging.
[72] Han-Chang Huang,et al. Protection of curcumin against amyloid-β-induced cell damage and death involves the prevention from NMDA receptor-mediated intracellular Ca2+ elevation , 2015, Journal of receptor and signal transduction research.
[73] R. Nitsch,et al. Calcium flux-independent NMDA receptor activity is required for Aβ oligomer-induced synaptic loss , 2015, Cell Death and Disease.
[74] N. Iwata,et al. Memantine Monotherapy for Alzheimer’s Disease: A Systematic Review and Meta-Analysis , 2015, PloS one.
[75] O. Garaschuk,et al. Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.
[76] L. Tan,et al. Brain-Derived Neurotrophic Factor in Alzheimer’s Disease: Risk, Mechanisms, and Therapy , 2015, Molecular Neurobiology.
[77] S. Lipton,et al. Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease , 2014, Molecular Neurodegeneration.
[78] Liping Huang,et al. Beta-asarone attenuates amyloid beta-induced autophagy via Akt/mTOR pathway in PC12 cells. , 2014, European journal of pharmacology.
[79] Brian C Coe,et al. Alzheimer's Disease-Like Pathology Induced by Amyloid-β Oligomers in Nonhuman Primates , 2014, The Journal of Neuroscience.
[80] Mary Ganguli,et al. Dementia and cognitive impairment: epidemiology, diagnosis, and treatment. , 2014, Clinics in geriatric medicine.
[81] K. Shinya,et al. Amyloid aggregation and deposition of human islet amyloid polypeptide at membrane interfaces , 2014, The FEBS journal.
[82] M. Mihăşan,et al. Inhalation of coriander volatile oil increased anxiolytic–antidepressant-like behaviors and decreased oxidative status in beta-amyloid (1–42) rat model of Alzheimer's disease , 2014, Physiology & Behavior.
[83] A. Spector,et al. Aromatherapy for dementia. , 2014, The Cochrane database of systematic reviews.
[84] Zhang Chunxi. Effects of Active Components of Rhizoma Acori Tatarinowii on APP and Synaptic Ultrastructure in Tg-APPswe/ PS1dE9 Mice , 2014 .
[85] Jin-Tai Yu,et al. Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis. , 2014, Journal of Alzheimer's disease : JAD.
[86] C. Bouras,et al. Neuropathology of parkinsonism in patients with pure Alzheimer's disease. , 2014, Journal of Alzheimer's disease : JAD.
[87] S. Rai,et al. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer’s Disease: Understanding the Therapeutics Strategies , 2014, Molecular Neurobiology.
[88] F. Islam,et al. 1,8-Cineole (Eucalyptol) Mitigates Inflammation in Amyloid Beta Toxicated PC12 Cells: Relevance to Alzheimer’s Disease , 2014, Neurochemical Research.
[89] M. Mesulam,et al. Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer's disease , 2013, The Journal of comparative neurology.
[90] M. Mihăşan,et al. Cognitive-enhancing and antioxidant activities of inhaled coriander volatile oil in amyloid β(1–42) rat model of Alzheimer's disease , 2013, Physiology & Behavior.
[91] D. Bredesen,et al. Ayurvedic medicinal plants for Alzheimer's disease: a review , 2012, Alzheimer's Research & Therapy.
[92] A. Gorji,et al. Anticonvulsant and neuroprotective effects of Pimpinella anisum in rat brain , 2012, BMC Complementary and Alternative Medicine.
[93] Jeongmin Lee,et al. Inhaled essential oil from Chamaecyparis obtuse ameliorates the impairments of cognitive function induced by injection of β-amyloid in rats , 2012, Pharmaceutical biology.
[94] Z. Azizi,et al. Amelioration of Amyloid β‐Induced Cognitive Deficits by Zataria multiflora Boiss. Essential Oil in a Rat Model of Alzheimer's Disease , 2012, CNS neuroscience & therapeutics.
[95] Hans-Ulrich Demuth,et al. Prion-Like Behavior and Tau-dependent Cytotoxicity of Pyroglutamylated β-Amyloid , 2012, Nature.
[96] W. Jian. Molecular Mechanisms Underlie Alzheimer-like Tau Hyperphosphorylation and Neurodegeneration , 2012 .
[97] B. Lyoussi,et al. Antioxidant and Antiacetylcholinesterase Activities of Some Commercial Essential Oils and Their Major Compounds , 2011, Molecules.
[98] S. Pugazhenthi,et al. Downregulation of CREB expression in Alzheimer's brain and in Aβ-treated rat hippocampal neurons , 2011, Molecular Neurodegeneration.
[99] Kuo-Chen Chou,et al. A Multi-Label Classifier for Predicting the Subcellular Localization of Gram-Negative Bacterial Proteins with Both Single and Multiple Sites , 2011, PloS one.
[100] Songhee Jeon,et al. SuHeXiang Wan essential oil alleviates amyloid beta induced memory impairment through inhibition of tau protein phosphorylation in mice. , 2011, The American journal of Chinese medicine.
[101] A. Lleó,et al. β-Amyloid Disrupts Activity-Dependent Gene Transcription Required for Memory through the CREB Coactivator CRTC1 , 2010, The Journal of Neuroscience.
[102] S. Yan,et al. Role of mitochondrial amyloid-beta in Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.
[103] Joseph E LeDoux,et al. Brain-derived neurotrophic factor: a dynamic gatekeeper of neural plasticity. , 2010, Current molecular pharmacology.
[104] K. Urakami,et al. Effect of aromatherapy on patients with Alzheimer's disease , 2009, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.
[105] Sang-H Choi,et al. The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research. , 2009, Trends in pharmacological sciences.
[106] Richard L Doty,et al. The olfactory system and its disorders. , 2009, Seminars in neurology.
[107] R. Hansen,et al. Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis , 2008, Clinical interventions in aging.
[108] I. Izquierdo,et al. BDNF is essential to promote persistence of long-term memory storage , 2008, Proceedings of the National Academy of Sciences.
[109] K. Mishima,et al. Spatial memory impairment without apoptosis induced by the combination of beta-amyloid oligomers and cerebral ischemia is related to decreased acetylcholine release in rats. , 2008, Journal of pharmacological sciences.
[110] A. Sartorius,et al. Elevated spectroscopic glutamate/&ggr;-amino butyric acid in rats bred for learned helplessness , 2007, Neuroreport.
[111] P. Tariot,et al. Meta-analysis of six-month memantine trials in Alzheimer’s disease , 2007, Alzheimer's & Dementia.
[112] D. Jun. Effect of rhizoma acori graminei on the secondary structure of amyloid beta-protein 25-35 , 2007 .
[113] T. Joh,et al. Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease , 2006, Experimental & Molecular Medicine.
[114] V. Perry,et al. Central and Systemic Endotoxin Challenges Exacerbate the Local Inflammatory Response and Increase Neuronal Death during Chronic Neurodegeneration , 2005, The Journal of Neuroscience.
[115] E. Ongini,et al. Non‐steroidal anti‐inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action , 2004, Journal of neurochemistry.
[116] E. Green,et al. A polymorphic variation in the interleukin 1A gene increases brain microglial cell activity in Alzheimer’s disease , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[117] R. Maccioni,et al. Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway. , 2004, Experimental cell research.
[118] H. W. Harris,et al. Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.